Ichor Microbial Solutions, Inc.

RALEIGH, NC · Founded 2023 · CIK 0002037447 · Biotech · Private

Monoclonal antibodies for in vivo research and therapeutic use

ichor.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.1M
2 Form D · Oct 2024
23 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 2 same dayForm D · SEC$550,000
Private capital raised· 2 of 2 same dayForm D · SEC$500,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2564Island Pharmaceuticals Ltd—$1.2M
2565LactaLogics, Inc.—$1.1M
2566MUCOMMUNE, LLC——
2567Ichor Microbial Solutions, Inc.—$1.1M
2568WAYPATH PHARMA LLC——
2569SENEX BIOTECHNOLOGY, INC.—$1.0M
2570Decoy Therapeutics, Inc.—$1.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • CHAD BROMMERDirector · Executive Officer
  • MATTHEW CRISPDirector · Executive Officer
  • DANIEL PEPITONEDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.